|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Expert Opin Pharmacother. 8(16):2701-17 |
Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics. |
Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Yamade M, Ikuma M, Watanabe H, Ohashi K, Hishida A, Ishizaki T.
Hamamatsu University School of Medicine, First Department of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan. mitsu@hama-med.ac.jp |
Publication Date: Wednesday, October 24, 2007
|
Click here to view MEDLINE citation |
|
More October, 2007 pharmacogenomics journal articles.- Advances in pharmacogenomics of antiretrovirals: an update.
by Ma Q, Brazeau D, Forrest A, Morse GD.
Journal: Pharmacogenomics. 8(9):1169-78
- Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.
by Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM.
Journal: Cancer Res. 67(20):9609-12
- Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.
by Gage BF, Lesko LJ.
Journal: J Thromb Thrombolysis. :
- Pharmacogenomics - The potential of genetically guided prescribing.
by Singh A.
Journal: Aust Fam Physician. 36(10):820-4
- Emergence and Evolution of Pharmacogenetics and Pharmacogenomics in Clinical Pharmacy over the Past 40 Years (December).
by Streetman DS.
Journal: Ann Pharmacother. :
- Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
by Cacabelos R.
Journal: Methods Find Exp Clin Pharmacol. 29 Suppl A:1-91
- Future relevance of genetic testing: A systematic horizon scanning analysis.
by Storz P, Kolpatzik K, Perleth M, Klein S, Häussler B.
Journal: Int J Technol Assess Health Care. 23(4):495-504
- Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.
by Erdélyi DJ, Kámory E, Csókay B, Andrikovics H, Tordai A, Kiss C, Félné-Semsei A, Janszky I, Zalka A, Fekete G, Falus A, Kovács GT, Szalai C.
Journal: Pharmacogenomics J. :
- Phase II pharmacogenomics-based adjuvant therapy trial in patients with non-small-cell lung cancer: Southwest Oncology Group Trial 0720.
by Bepler G.
Journal: Clin Lung Cancer. 8(8):509-11
- Pharmacogenomics in clinical trials: An analysis.
by Chowta MN, Adhikari PM, Ramesh KV, Shenoy AK.
Journal: Indian J Med Sci. 61(10):574-6
- Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.
by Henry NL, Giles JT, Ang D, Mohan M, Dadabhoy D, Robarge J, Hayden J, Lemler S, Shahverdi K, Powers P, Li L, Flockhart D, Stearns V, Hayes DF, Storniolo AM, Clauw DJ.
Journal: Breast Cancer Res Treat. :
- Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism.
by Rodríguez-Antona C, Niemi M, Backman JT, Kajosaari LI, Neuvonen PJ, Robledo M, Ingelman-Sundberg M.
Journal: Pharmacogenomics J. :
- GPCR NaVa database: natural variants in human G protein-coupled receptors.
by Kazius J, Wurdinger K, van Iterson M, Kok J, Bäck T, Ijzerman AP.
Journal: Hum Mutat. :
- Effect of angiotensin-converting enzyme insertion/deletion genotype on collagen type I synthesis and degradation in patients with atrial fibrillation and arterial hypertension.
by Tziakas DN, Chalikias GK, Stakos DA, Papazoglou D, Papanas N, Papatheodorou K, Chatzikyriakou SV, Kotsiou S, Maltezos E, Boudoulas H.
Journal: Expert Opin Pharmacother. 8(14):2225-34
- Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes.
by Tolstrup JS, Nordestgaard BG, Rasmussen S, Tybjærg-Hansen A, Grønbæk M.
Journal: Pharmacogenomics J. :
- Pharmacogenetics of acute lymphoblastic leukemia treatment response.
by Cunningham L, Aplenc R.
Journal: Expert Opin Pharmacother. 8(15):2519-31
- Warfarin Pharmacogenetics: Economic Considerations.
by Hughes DA, Pirmohamed M.
Journal: Pharmacoeconomics. 25(11):899-902
- Genetic variation of estrogen metabolism and the risks of cardiovascular disease.
by Almeida S, Hutz MH.
Journal: Curr Opin Investig Drugs. 8(10):814-20
- Pharmacogenomics of lung cancer: with a view to address EGFR-targeted therapies.
by Joshi VA, Kucherlapati R.
Journal: Pharmacogenomics. 8(9):1211-20
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|